News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
According to the Sweden-headquartered CRO, the company’s CEO, Daniel Spasic, chose to leave his position after founding the company and serving in the position since 1996. He will remain an owner of TFT with 40% of the shares
James Utterback, an advisor to the Board of Directors of TFS has been appointed acting CEO as the company begins the recruitment process to find a permanent replacement.
In addition to announcing Spasic’s departure, the company has also announced several new positions, including Ryan Shortreed as chief financial officer, Martin Filippides as vice president human resources and Young Shon as chief information officer.
Ryan Shortreed joins TFS from Parexel where we was the vice president of finance. He will be based out of the TFS office in Princeton, NJ, USA.
Filippides was vice president Global HR at Quintiles Transnational for eight years and will be based out of the TFS office in Uxbridge, UK.